Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02220985

Recruitment Status : Active, not recruiting

First Posted : August 20, 2014

Last Update Posted : December 24, 2020

Sponsor:

Collaborators:

National Cancer Institute (NCI)

National Heart, Lung, and Blood Institute (NHLBI)

Information provided by (Responsible Party):

Fred Hutchinson Cancer Research Center

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	April 1, 2025
Estimated Study Completion Date :	April 1, 2025

To Top